The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGamma Communications Regulatory News (GAMA)

Share Price Information for Gamma Communications (GAMA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,344.00
Bid: 1,334.00
Ask: 1,338.00
Change: 2.00 (0.15%)
Spread: 4.00 (0.30%)
Open: 1,338.00
High: 1,360.00
Low: 1,326.00
Prev. Close: 1,342.00
GAMA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

8 Sep 2020 07:00

RNS Number : 2792Y
Gamma Communications PLC
08 September 2020
 

8 September 2020

Gamma Communications plc

 

Non-Executive Director Appointments

 

Gamma Communications plc ("Gamma" or "the Group"), a leading, technology based provider of communications services to the business market in Western Europe announces the appointment of Xavier Robert and Charlotta Ginman as Non-Executive Directors of the Company with immediate effect.

 

Xavier has been a private equity professional for more than 20 years. He leads the investment activities of global private equity firm Bridgepoint in the UK and sits on its Executive and Investment Committees. He holds a strong expertise in TMT and notably chairs Calypso, a leading global capital market software provider, and Qualitest, the global market leading pure-play software testing company.

 

Charlotta qualified as a Chartered Accountant before spending a career in investment banking and commercial organisations, principally in technology-related businesses. She began her career at Ernst & Young in 1989, and was then appointed to a series of senior roles in investment banking with UBS, Deutsche Bank and JP Morgan both in London and Singapore.

 

Charlotta has also held senior roles within Nokia Corporation, including acting as Chief Financial Officer of its luxury mobile phone division Vertu Corporation Limited. Charlotta is an experienced NED, currently sitting on the Boards of Pacific Assets Trust plc, Polar Capital Technology Trust plc, Unicorn AIM VCT plc and Keywords Studios plc.

 

Richard Last, Chairman of Gamma, said:

 

"I'm very pleased to welcome Xavier and Charlotta to the Board. Charlotta has extensive technology sector experience from multinational incumbents such as Nokia and fast growth software and service providers like Keywords Studios. As an executive and NED she has supported the growth and development of businesses in the sector and will provide valuable insight as Gamma continues to execute its strategy.

 

 

Xavier's experience in identifying, acquiring, integrating and growing technology businesses is highly relevant to Gamma's international acquisition strategy. As we grow our footprint in both existing and new jurisdictions across Western Europe we look forward to his insight complementing the experience already on the Board."

 

 

Enquiries:

 

Gamma Communications plc Tel: +44 (0)333 006 5972

Andrew Taylor, Chief Executive Officer

Andrew Belshaw, Chief Financial Officer

 

Investec Bank plc (NOMAD & Broker) Tel: +44 (0)207 597 5970

Virginia Bull

Patrick Robb

 

Tulchan Communications LLP (PR Adviser) Tel: +44 (0)207 353 4200

James Macey White

Matt Low

 

 

Additional Information:

Disclosures under Schedule 2 of the AIM Rules:

 

The following additional information relating to Mr Robert is disclosed under Rule 17 or Schedule 2 paragraph (g) of the AIM Rules for Companies.

 

Mr Xavier Jean Robert, aged 49, holds or has held the following directorships and/or partnerships in the previous five years:

 

Current directorships/partnerships

Past Directorships/partnerships

CALYPSO GROUP LUX SCA

CALYPSO GROUP UK LIMITED

QUANTUM HOLDING TOPCO LIMITED

SCI NOAILLES

 

 

BRIDGEPOINT ADVISERS II LIMITED

BRIDGEPOINT ADVISERS HOLDINGS

BRIDGEPOINT SP. Z O.O.

COMPAGNIE DU PONANT HOLDING

CALYPSO FX USD LIMITED

CALYPSO FX EUR LIMITED

CALYPSO GROUP US, INC

CALYPSO MERGER CO.

CALYPSO UK MIDCO LIMITED

CALYPSO UK TOPCO LIMITED

EFRONT HOLDING SAS

EFRONT MANCO

MAPIL TOPCO LIMITED

QUANTUM HOLDCO BIDCO INC

QUANTUM HOLDING FINCO LIMITED

QUANTUM HOLDING MIDCO 1 LIMITED

QUANTUM HOLDING MIDCO 2 LIMITED

QUANTUM HOLDING UK BIDCO LIMITED

 

Mr Robert was a director of Groupe Moniteur when it was subject to a scheme of arrangement and sold to a competitor post the global financial crisis.

 

No additional information relating to Mr Robert is required to be disclosed under Rule 17 or Schedule 2 paragraph (g) of the AIM Rules for Companies.

 

 

 

The following additional information relating to Ms Ginman is disclosed under Rule 17 or Schedule 2 paragraph (g) of the AIM Rules for Companies.

 

Ms Maria Charlotta Ginman FCA, aged 55, holds or has held the following directorships and/or partnerships in the previous five years:

 

Current directorships/partnerships

Past Directorships/partnerships

Keywords Studios plc

Polar Capital Technology Trust plc

Pacific Assets Trust plc

Unicorn AIM VCT plc

The Queen's Club Limited

QC Holdings Limited

QC Ground Limited

 

Consort Medical PLC

Motif Bio plc

Kromek plc

Motif BioSciences, Inc

 

 

Ms Ginman' has also been known by the following surnames: Ginman-Horrell (current married name) and Ginman-Jones (former married name).

 

No additional information relating to Ms Ginman is required to be disclosed under Rule 17 or Schedule 2 paragraph (g) of the AIM Rules for Companies.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUPUMUBUPUGBM
Date   Source Headline
1st Feb 20235:47 pmRNSTotal Voting Rights
27th Jan 202312:44 pmRNSHolding(s) in Company
18th Jan 20235:21 pmRNSHolding(s) in Company
17th Jan 202310:34 amRNSDirector/PDMR Shareholding
12th Jan 20237:00 amRNSFull year growth expectations remain unchanged
11th Jan 20232:30 pmRNSTotal Voting Rights
11th Jan 20231:28 pmRNSHolding(s) in Company
10th Jan 202311:47 amRNSHolding(s) in Company
6th Jan 20234:08 pmRNSHolding(s) in Company
20th Dec 20227:00 amRNSChange of Senior Independent Director
19th Dec 202211:58 amRNSHolding(s) in Company
16th Dec 20223:31 pmRNSHolding(s) in Company
15th Dec 20226:26 pmRNSDirector/PDMR Shareholding
5th Dec 20225:15 pmRNSTotal Voting Rights
30th Nov 20227:00 amRNSChief Executive Officer Appointment
15th Nov 20226:04 pmRNSDirector/PDMR Shareholding
15th Nov 20223:44 pmRNSHolding(s) in Company
9th Nov 20228:53 amRNSBlock listing Interim Review
8th Nov 20222:17 pmRNSHolding(s) in Company
1st Nov 20223:18 pmRNSTotal Voting Rights
28th Oct 20224:54 pmRNSChange of Registered Office
27th Oct 20224:49 pmRNSDirector/PDMR Shareholding
17th Oct 20226:23 pmRNSDirector/PDMR Shareholding
13th Oct 20222:14 pmRNSHolding(s) in Company
10th Oct 202211:29 amRNSDirector/PDMR Shareholding
3rd Oct 20225:59 pmRNSTotal Voting Rights
3rd Oct 20224:44 pmRNSNon-Executive Director Appointment
27th Sep 20222:44 pmRNSDirector/PDMR Shareholding
15th Sep 202211:13 amRNSHolding(s) in Company
13th Sep 20224:52 pmRNSDirector/PDMR Shareholding
7th Sep 20226:10 pmRNSHolding(s) in Company
6th Sep 20227:00 amRNSHalf-year Report
31st Aug 20224:04 pmRNSHolding(s) in Company
16th Aug 202211:52 amRNSDirector/PDMR Shareholding
5th Aug 20225:23 pmRNSHolding(s) in Company
3rd Aug 202210:09 amRNSHolding(s) in Company
2nd Aug 20222:18 pmRNSTotal Voting Rights
2nd Aug 202210:25 amRNSHolding(s) in Company
2nd Aug 20227:00 amRNSH1 Trading Update
22nd Jul 20224:44 pmRNSHolding(s) in Company
21st Jul 20225:38 pmRNSHolding(s) in Company
19th Jul 20225:06 pmRNSDirector/PDMR Shareholding
13th Jul 20226:07 pmRNSDirector/PDMR Shareholding
8th Jul 20224:39 pmRNSIssue of Equity
6th Jul 20224:01 pmRNSDirector/PDMR Shareholding
5th Jul 20224:21 pmRNSTotal Voting Rights
1st Jul 202212:37 pmRNSDirectorate Change
30th Jun 202210:35 amRNSHolding(s) in Company
30th Jun 20227:00 amRNSDirectorate Change
16th Jun 20229:07 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.